Current best practices for acute and chronic management of patients with opioid use disorder

A Peterkin, J Laks, ZM Weinstein - Medical Clinics, 2022 - medical.theclinics.com
The current opioid use epidemic originates in a long history of opium use, trade, and
criminalization dating back to ancient civilizations. 1 In the United States, opium …

Association of early opioid withdrawal treatment strategy and patient-directed discharge among hospitalized patients with opioid use disorder

M Alrawashdeh, C Rhee, M Klompas… - Journal of General …, 2023 - Springer
Background Medical hospitalizations for people with opioid use disorder (OUD) frequently
result in patient-directed discharges (PDD), often due to untreated pain and withdrawal …

Retention in the Austrian opioid agonist treatment system: a national prospective cohort study

M Busch, C Klein, A Uhl, H Haltmayer, M Cabanis… - Harm Reduction …, 2021 - Springer
Background Retention in care is a prerequisite for successful recovery, especially for a
chronic condition like opioid dependence. Though retention varies greatly depending on the …

Access and care for people with opioid use disorder in US skilled nursing facilities: A policy commentary

S Nishar, J Soske, R Vanjani, SD Kimmel… - International Journal of …, 2024 - Elsevier
Referrals for people with opioid use disorder (OUD) to skilled nursing facilities (SNFs) are
increasing in the United States (US). Further, legal guidance from the US Department of …

Outpatient rapid titration of slow release oral morphine for the treatment of opioid use disorder in a Canadian setting: a case series

O Brooks, JCY Ng, S Ickowicz - Journal of addiction medicine, 2023 - journals.lww.com
Discussion In the cases described, substantial reductions in unregulated fentanyl use and
social gains, such as obtaining housing, employment, and enrollment in inpatient treatment …

Uptake of slow‐release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder

TD Brothers, J Fraser, E MacAdam… - Drug and alcohol …, 2022 - Wiley Online Library
Introduction Buprenorphine and methadone are highly effective first‐line medications for
opioid agonist treatment (OAT) but are not acceptable to all patients. We aimed to assess the …

[HTML][HTML] Public Perceptions of Treating Opioid Use Disorder With Deep Brain Stimulation: Comment Analysis Study

P Henegan, J Koczara, R Bluhm… - Online Journal of Public …, 2024 - ojphi.jmir.org
Background: The number of opioid-related deaths in the United States has more than tripled
over the past 7 years, with a steep increase beginning at the same time as the COVID-19 …

[PDF][PDF] Towards an Improved Substance Use Disorder Treatment Landscape in Rhode Island–Barriers, Current Progress, and Next Steps

HM Braun, C Wunsch, SA Clark - Rhode Island Medical Journal, 2022 - rimed.org
Expanding addiction treatment services in Rhode Island has never been more urgent.
Today, we face colliding syndemics of COVID-19, preventable drug overdoses, and HIV …

Caring for individuals with concurrent mental health and opioid use disorder: a mixed-methods study with implications for health research, policy and practice

TA Beaulieu - 2022 - open.library.ubc.ca
Background: The co-occurrence of opioid use disorder (OUD) and mental illness is common
and may lead to poor negative health and social outcomes, as compared with having either …

Prevention of 90-day Detox Readmission for Opioid use Disorder by A Community-Based Life-Changing Individualized Medically Assisted Evidence-based Treatment …

Z Luo, C Roychoudhury, WS Pompos, J DiMaria… - 2022 - researchsquare.com
Background: Evidence for community-based detox readmission prevention strategies for
opioid use disorder (OUD) is scant. We evaluated a pilot program designed to provide …